Founded in 1991, Paul Capital is a pioneer in the private equity secondary market, providing creative liquidity solutions for investors in private equity limited partnerships and portfolios of direct investments. The company expanded its offerings in 1999 with the addition of a Healthcare Platform, investing in royalty and revenue interests in life science products. Today, Paul Capital leverages its extensive experience and unique insights to develop compelling solutions for institutional investors. With offices in Hong Kong, London, New York, Paris, San Francisco, and São Paulo, the company manages over $6 billion across three distinct investment platforms, including a fund of funds, secondary investments, and a healthcare direct investment business.